Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:
”Activin receptor ligand traps continue to show promise in the treatment of anemia of myelofibrosis.
Check out the results of the first clinical trial to explore this class of drugs in MF here Haematologica.”
Source: Hagop Kantarjian/X